NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Completed · Not applicable

Conditions studied: Lung Cancer, Lung Tumor

In brief

The purpose of this post approval study is to further characterize the safety profile of the ProGEL™ Pleural Air Leak Sealant in commercial use, with specific reference to long-term safety over 90 days of follow-up.

Key facts

Study ID
NCT01394978
Run by
C. R. Bard
People needed
444
Starts
2011-06-01
Expected to finish
2016-02-01
Last updated by the study team
2021-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.